X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Orchid Chemicals with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs ACTAVIS (US) - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ORCHID PHARMA LTD   ACTAVIS
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
ACTAVIS
Dec-14
ORCHID PHARMA LTD/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs19418,561-   
Low Rs3511,322-   
Sales per share (Unadj.) Rs276.53,342.4-  
Earnings per share (Unadj.) Rs-79.2-417.1-  
Cash flow per share (Unadj.) Rs-43.5306.7-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs53.97,249.5-  
Shares outstanding (eoy) m70.45265.90-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.44.5 9.3%   
Avg P/E ratio x-1.4-35.8 4.0%  
P/CF ratio (eoy) x-2.648.7 -5.4%  
Price / Book Value ratio x2.12.1 103.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m8,0673,972,967 0.2%   
No. of employees `0002.821.6 13.0%   
Total wages/salary Rs m2,5270-   
Avg. sales/employee Rs Th6,956.141,145.3 16.9%   
Avg. wages/employee Rs Th902.50-   
Avg. net profit/employee Rs Th-1,993.0-5,134.5 38.8%   
INCOME DATA
Net Sales Rs m19,477888,738 2.2%  
Other income Rs m407-2,218 -18.4%   
Total revenues Rs m19,884886,520 2.2%   
Gross profit Rs m1,103114,171 1.0%  
Depreciation Rs m2,519192,444 1.3%   
Interest Rs m5,22728,032 18.6%   
Profit before tax Rs m-6,236-108,524 5.7%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m511-7,961 -6.4%   
Tax Rs m-125-5,579 2.2%   
Profit after tax Rs m-5,580-110,905 5.0%  
Gross profit margin %5.712.8 44.1%  
Effective tax rate %2.05.1 39.1%   
Net profit margin %-28.7-12.5 229.6%  
BALANCE SHEET DATA
Current assets Rs m11,014468,251 2.4%   
Current liabilities Rs m32,060341,493 9.4%   
Net working cap to sales %-108.114.3 -757.6%  
Current ratio x0.31.4 25.1%  
Inventory Days Days9558 163.5%  
Debtors Days Days3466 50.6%  
Net fixed assets Rs m29,440108,524 27.1%   
Share capital Rs m7050-   
"Free" reserves Rs m2,0430-   
Net worth Rs m3,8001,927,641 0.2%   
Long term debt Rs m9,0181,010,122 0.9%   
Total assets Rs m46,5103,532,732 1.3%  
Interest coverage x-0.2-2.9 6.7%   
Debt to equity ratio x2.40.5 452.9%  
Sales to assets ratio x0.40.3 166.5%   
Return on assets %-0.8-2.3 32.4%  
Return on equity %-146.9-5.8 2,552.5%  
Return on capital %-3.7-3.0 124.0%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Net fx Rs m1,8650-   
CASH FLOW
From Operations Rs m1,682152,614 1.1%  
From Investments Rs m-9,860-365,416 2.7%  
From Financial Activity Rs m6,644205,311 3.2%  
Net Cashflow Rs m-1,535-7,491 20.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 68.04 Rs / USD

Compare ORCHID PHARMA LTD With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ORCHID PHARMA LTD With: TTK HEALTHCARE  PFIZER  JUBILANT LIFE SCIENCES  STERLING BIOTECH  WYETH LTD  



Today's Market

Sensex Trades Rangebound; Metal, Pharma Stocks Top Losers(12:30 pm)

After opening the day flat share markets in India are trading on a dull note and are presently trading below the dotted line.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jun 18, 2018 03:21 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - SUN PHARMA COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS